Cover Image

Efficacy and safety of a personalized vitamin D3 loading dose followed by daily 2000 IU in colorectal cancer patients with vitamin D insufficiency: interim analysis of a randomized controlled trial

A personalized vitamin D3 loading dose has not yet been tested in cancer patients. This interim analysis of the randomized, placebo-controlled VICTORIA trial analyzed the first recruited 74 German adults with nonmetastatic colorectal cancer, a tumor surgery within the past year, and 25-hydroxyvitami...

Full description

Saved in:
Bibliographic Details
Main Authors: Kuznia, Sabine (Author) , Czock, David (Author) , Kopp-Schneider, Annette (Author) , Caspari, Reiner (Author) , Fischer, Harald (Author) , Laetsch, Dana Clarissa (Author) , Slavic, Marija (Author) , Brenner, Hermann (Author) , Schöttker, Ben (Author)
Format: Article (Journal)
Language:English
Published: 28 October 2022
In: Nutrients
Year: 2022, Volume: 14, Issue: 21, Pages: 1-15
ISSN:2072-6643
DOI:10.3390/nu14214546
Online Access:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.3390/nu14214546
Verlag, lizenzpflichtig, Volltext: https://www.mdpi.com/2072-6643/14/21/4546
Get full text
Author Notes:Sabine Kuznia, David Czock, Annette Kopp-Schneider, Reiner Caspari, Harald Fischer, Dana Clarissa Laetsch, Marija Slavic, Hermann Brenner and Ben Schöttker
Description
Summary:A personalized vitamin D3 loading dose has not yet been tested in cancer patients. This interim analysis of the randomized, placebo-controlled VICTORIA trial analyzed the first recruited 74 German adults with nonmetastatic colorectal cancer, a tumor surgery within the past year, and 25-hydroxyvitamin D levels (25(OH)D) < 50 nmol/L.
Item Description:Gesehen am 31.01.2023
Physical Description:Online Resource
ISSN:2072-6643
DOI:10.3390/nu14214546

Similar Items